NCT06557057
- Conditions
- HER2-Positive Breast Carcinoma
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
HER2-Positive Breast Carcinoma
Explore clinical trials studying HER2-Positive Breast Carcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
HER2-Positive Breast Carcinoma trial results
Recruiting
Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
NCT04517838
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +3 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Active, not recruiting
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
NCT05710328
- Conditions
- Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, +1 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
NCT04704661
- Conditions
- Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, not recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT04550494
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
- Locations
-
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
NCT03179904
- Conditions
- Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +2 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02003209
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-Positive Breast Carcinoma, +11 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
NCT01622868
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States